These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6720727

  • 21. Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972-3.
    Holme I, Kjeldsen SE.
    Eur J Intern Med; 2015 Mar; 26(2):123-6. PubMed ID: 25681139
    [Abstract] [Full Text] [Related]

  • 22. Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion.
    Dornhorst A, Powell SH, Pensky J.
    Lancet; 1985 Jan 19; 1(8421):123-6. PubMed ID: 2857210
    [Abstract] [Full Text] [Related]

  • 23. [Effect of long-term treatment with propranolol or hydrochlorothiazide on biochemical risk factors of coronary disease in patients with hypertension].
    Witkowska M, Lukasik S, Kawecka M, Moszczyńska J, Karolko B.
    Kardiol Pol; 1989 Jan 19; 32 Suppl 2():25-32. PubMed ID: 2634150
    [Abstract] [Full Text] [Related]

  • 24. Combination of a thiazide, a vasodilator and reserpine compared with methyldopa plus hydrochlorothiazide in the treatment of hypertension in Zimbabwe.
    Stein CM, Neill P, Mwaluko GM, Kusema T.
    S Afr Med J; 1990 Mar 03; 77(5):243-5. PubMed ID: 2107581
    [Abstract] [Full Text] [Related]

  • 25. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982 Mar 03; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

  • 26. An appraisal of antihypertensive efficacy and adverse reactions with two drug regimens: enalapril maleate as part of triple therapy compared to conventional triple therapy in moderate to severe hypertension.
    Fernandez PG, Kim BK, Galway AB.
    Pharmatherapeutica; 1984 Mar 03; 3(8):505-14. PubMed ID: 6322207
    [Abstract] [Full Text] [Related]

  • 27. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.
    Jeunemaitre X, Charru A, Chatellier G, Degoulet P, Julien J, Plouin PF, Corvol P, Ménard J.
    Am J Cardiol; 1988 Nov 15; 62(16):1072-7. PubMed ID: 3189169
    [Abstract] [Full Text] [Related]

  • 28. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    Br J Clin Pharmacol; 1982 Nov 15; 13(Suppl 2):441S-444S. PubMed ID: 7104158
    [Abstract] [Full Text] [Related]

  • 29. Impact of antihypertensive therapy on quality of life: effect of hydrochlorothiazide.
    Williams GH, Croog SH, Levine S, Testa MA, Sudilovsky A.
    J Hypertens Suppl; 1987 Feb 15; 5(1):S29-35. PubMed ID: 3553493
    [Abstract] [Full Text] [Related]

  • 30. Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
    Damian DJ, McNamee R, Carr M.
    BMC Cardiovasc Disord; 2016 Oct 04; 16(1):188. PubMed ID: 27716064
    [Abstract] [Full Text] [Related]

  • 31. The progress of patients in the European Working Party on Hypertension in the Elderly trial.
    Amery A, Beard K, Birkenhäger W, Bogaert M, Brixko P, Bulpitt C, Clement D, de Leeuw P, De Plaen JF, Deruyettere M.
    Acta Med Scand Suppl; 1983 Oct 04; 676():119-40. PubMed ID: 6362343
    [Abstract] [Full Text] [Related]

  • 32. The effects of bendroflumethiazide/potassium chloride versus hydrochlorothiazide/amiloride on blood pressure and serum electrolytes in patients with mild to moderate hypertension seen in general practice.
    Jørgensen F, Bredesgaard P, Johansen P.
    Pharmatherapeutica; 1986 Oct 04; 4(10):655-64. PubMed ID: 3602017
    [Abstract] [Full Text] [Related]

  • 33. Initial antihypertensive therapy. Comparison of prazosin and hydrochlorothiazide.
    Alderman MH, Davis TK, Carroll L.
    Am J Med; 1986 Feb 14; 80(2A):120-5. PubMed ID: 3511691
    [Abstract] [Full Text] [Related]

  • 34. Safety and efficacy of a three-drug regimen for the treatment of hypertension: hydrochlorothiazide, propranolol, and guanadrel.
    Gore RD.
    Clin Ther; 1983 Feb 14; 6(1):86-93. PubMed ID: 6673832
    [Abstract] [Full Text] [Related]

  • 35. Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension.
    Drayer JI, Weber MA, Gardin JM, Lipson JL.
    Am J Med; 1983 Sep 26; 75(3A):116-20. PubMed ID: 6226188
    [Abstract] [Full Text] [Related]

  • 36. [Biochemical changes in hypertensive patients during a 1-year cross-over study of treatment with hydrochlorothiazide and propranolol].
    Bagatin J, Rumboldt Z, Polić S, Sardelić S, Ljutić D, Capkun V, Pivac N, Petrović P, Bojić L.
    Lijec Vjesn; 1996 Sep 26; 118(1-2):11-6. PubMed ID: 8759414
    [Abstract] [Full Text] [Related]

  • 37. Prazosin versus propranolol plus prazosin: a comparison in diuretic-treated hypertensive patients.
    Kochar MS, Kalbfleisch JH, Blumenthal SS, Maierhofer WJ.
    Am J Cardiol; 1984 Jan 27; 53(3):55A-58A. PubMed ID: 6695766
    [Abstract] [Full Text] [Related]

  • 38. Comparison of low-dose captopril and propranolol as second-line drugs in mild and moderate hypertension.
    Traub YM, Rosenfeld JB.
    Isr J Med Sci; 1985 Sep 27; 21(9):737-41. PubMed ID: 3902720
    [Abstract] [Full Text] [Related]

  • 39. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS, Farsky K, Bouchard S, Lalonde Y, Brookman S.
    Clin Ther; 1985 Sep 27; 7(2):199-204. PubMed ID: 3886142
    [Abstract] [Full Text] [Related]

  • 40. Step 2 regimens in hypertension. An assessment.
    Finnerty FA, Gyftopoulos A, Berry C, McKenney A.
    JAMA; 1979 Feb 09; 241(6):579-81. PubMed ID: 762813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.